NOAC plus aspirin cuts stroke risk in half

The combination is particularly effective for secondary stroke

A low-dose anticoagulant combined with low-dose aspirin may have a role in preventing stroke in patients with stable atherosclerotic vascular disease.

pills

Research presented last week shows that a combination of the non-vitamin K oral anticoagulant (NOAC) rivaroxaban plus aspirin cut the ischaemic stroke rate by almost half without significantly increasing the risk for intracerebral haemorrhage (ICH), compared with aspirin alone.

The combination is particularly effective for secondary stroke prevention, lead researcher Dr Mike Sharma from

Latest

Trending